Andere Sprachen Eagle Pharmaceuticals, Inc.

Aktien

A1XEDS

US2697961082

EGRX

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 24.04.2024			% 5 Tage	% 1. Jan.
4,55 ^USD	-4,61 %		+3,64 %	-13,00 %

11.03.	Sektor-Update: Aktien des Gesundheitswesens am späten Nachmittag schwächer	MT
11.03.	Sektor Update: Gesundheitswesen	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

North American Morning Briefing : Stock Futures -2-	22.04.
Eagle Pharmaceuticals to Present Additional Data from Phase III Trial Demonstrating Sustained Response of Amisulpride for the Rescue Treatment of Postoperative Nausea and Vomiting	16.04.
Sector Update: Health Care Stocks Softer Late Afternoon	15.04.
Sector Update: Health Care	15.04.
Eagle Pharmaceuticals Says Phase 3 Data Show Amisulpride's Sustained Antiemetic Effect; Shares Rise	15.04.
Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Annual Report on Form 10-K	15.04.
Eagle Pharmaceuticals to Present Additional Data from Phase III Trial Demonstrating Sustained Response of Amisulpride for the Rescue Treatment of Postoperative Nausea and Vomiting (PONV) at the Upcoming ASPAN 2024 National Conference in Orlando, Florida	15.04.
North American Morning Briefing : Stock Futures -2-	15.04.
Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Annual Report on Form 10-K	12.04.
North American Morning Briefing : Inflation Data, -2-	08.04.
North American Morning Briefing : Tech in Focus on -2-	25.03.
North American Morning Briefing : Investors -2-	18.03.
Sector Update: Health Care Stocks Softer Late Afternoon	11.03.
Sector Update: Health Care	11.03.
Eagle Pharmaceuticals CFO Resigns; Shares Fall	11.03.
North American Morning Briefing : Stock Futures -2-	11.03.
Eagle Pharmaceuticals, Inc. Announces CFO Changes	08.03.
Eagle Pharmaceuticals, Inc. Announces Board and Committee Changes	08.03.
Eagle Pharmaceuticals, Inc. Enters into Second Amendment to Third Amended and Restated Credit Agreement	01.03.
Eagle Pharmaceuticals Idles 36% Workforce -- Shares Down	29.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Eagle Pharmaceuticals, Inc.

Aktien

A1XEDS

US2697961082

EGRX

Andere Sprachen

Filter